Skip to main content
Log in

Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Cavalli FMG, Remke M, Rampasek L et al (2017) Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31:737–754

    Article  CAS  PubMed  Google Scholar 

  2. Jones DT, Jager N, Kool M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100–105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kline CN, Joseph NM, Grenert JP et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncol 19:699–709

    PubMed  Google Scholar 

  4. Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123:473–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Morrissy AS, Cavalli FMG, Remke M et al (2017) Spatial heterogeneity in medulloblastoma. Nat Genet 49:780–788

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Northcott PA, Buchhalter I, Morrissy AS et al (2017) The whole-genome landscape of medulloblastoma subtypes. Nature 547:311–317

    Article  CAS  PubMed  Google Scholar 

  7. Northcott PA, Korshunov A, Witt H et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408–1414

    Article  PubMed  Google Scholar 

  8. Northcott PA, Shih DJ, Peacock J et al (2012) Subgroup-specific structural variation across 1000 medulloblastoma genomes. Nature 488:49–56

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pugh TJ, Weeraratne SD, Archer TC et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106–110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

J.B.I. is supported by the Arthur Purdy Stout Stipend Award. B.C.B. is supported by an NCI Outstanding Investigator Award (R35 CA220481). D.A.S. is supported by NIH Director’s Early Independence Award (DP5 OD021403).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David A. Solomon.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests related to this report.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLSX 32 kb)

Supplementary material 2 (PDF 12338 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iorgulescu, J.B., Van Ziffle, J., Stevers, M. et al. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation. Acta Neuropathol 135, 635–638 (2018). https://doi.org/10.1007/s00401-018-1819-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-018-1819-x

Navigation